NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-130-2022-3-EP-02 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE EP DIV 23202240.0 Pending
NCI E-237-2017-2-EA-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 EA DIV 202392526 Pending
NICHD E-210-2021-0-US-04 Kits And Methods For Predictions And Treatment Of Preeclampsia US CON 18/482,286 Pending
NIAID E-239-2020-0-EP-01 RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE EP National Stage 22724539.6 Pending
NCI E-118-2021-0-CA-01 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors CA National Stage 3216228 Pending
NHLBI E-090-2020-1-US-01 NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE US CIP 18/480,306 Pending
NCI E-182-2017-0-SG-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION SG DIV 10202302822Q Pending
NCI E-171-2018-7-JP-01 MODIFIED CELLS AND METHODS OF THERAPY JP DIV 2023-171191 Pending
NHLBI E-223-2022-0-PC-01 Physiological Navigation In MRI Using Inherent Slab-selective Free-induction-decay Signal PCT PCT PCT/US2023/033997 Pending
NIDA E-208-2022-0-PCT-01 Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders PCT PCT PCT/US2023/033932 Pending
NCI E-237-2017-1-SG-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION SG DIV 10202302739V Pending
NCATS E-039-2021-0-EP-01 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION EP National Stage 22714325.2 Pending
NIDDK E-001-2022-0-US-02 MOTOR FOR A MR ELASTOGRAPHY TRANSDUCER US CON 18/474,332 Pending
NCI E-494-2013-0-AU-01 Methods of Preparing Anti-human Papillomavirus Antigen T Cells AU DIV 2023233209 Pending
NIAID E-212-2022-0-PC-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE PCT PCT PCT/US2023/074791 Pending
NCI E-065-2021-0-CA-01 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF CA National Stage 3212978 Pending
NCI E-175-2016-0-AU-01 ANTI-KRAS-G12D T CELL RECEPTORS AU DIV 2023233125 Pending
NCI E-028-2015-1-EP-01 Anti-Mutated Kras T Cell Receptors EP DIV 23198524.3 Pending
NCATS E-244-2014-0-JP-02 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof JP DIV 2023-135162 Pending
NCI E-231-2017-0-US-02 IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN US DIV 18/471,137 Pending
NCI E-065-2021-0-US-02 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF US National Stage 18/282,919 Pending
NICHD E-058-2021-0-EP-01 La Protein As A Novel Regulator Of Osteoclastogenesis EP National Stage 22711784.3 Pending
NIAMS E-244-2020-0-EP-01 SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2 EP National Stage 22708683.2 Issued
NHLBI E-056-2021-0-CN-01 A New Molecular Scaffold For Targeting HRpn13 CN National Stage 202280022424.0 Pending
NCI E-111-2021-0-US-02 CANCER VACCINE AND METHOD OF USE THEREOF US National Stage 18/550,895 Pending
NIAID E-045-2021-0-EP-01 COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE EP National Stage 22709536.1 Pending
NCI E-029-2021-0-EP-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD22 EP National Stage 22709092.5 Pending
NCATS E-039-2021-0-US-02 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION US National Stage 18/550,239 Pending
NCI E-237-2017-2-NZ-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ DIV 803551 Pending
NCI E-237-2017-2-NZ-04 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ DIV 803564 Pending
NCI E-237-2017-2-NZ-02 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ DIV 803557 Pending
NCI E-237-2017-2-NZ-03 T CELL RECEPTORS RECOGNIZING MUTATED P53 NZ DIV 803561 Pending
NIAID E-081-2013-4-US-01 PREFUSION RSV F PROTEINS AND THEIR USE US CON 18/464,786 11981707 Issued PDF
NIAID E-081-2013-4-US-27 PREFUSION RSV F PROTEINS AND THEIR USE US DIV Pending
NIDDK E-051-2021-0-CN-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS CN National Stage 202280020636.5 Abandoned
NIAID E-037-2021-1-KR-11 Antibodies Targeting The Spike Protein Of Coronaviruses KR National Stage 10-2023-7030836 Pending
NCI E-040-2012-0-JP-01 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen JP DIV 2023-146498 Pending
CC E-096-2016-0-US-04 POWERED GAIT ASSISTANCE SYSTEMS US CON 18/243,573 Pending
NIAID E-185-2022-0-PC-01 Engineered SARS-CoV-2 Antibodies With Increased Neutralization Breadth PCT PCT PCT/US2023/073517 Pending
NIAID E-260-2014-0-US-07 RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE US DIV 18/462,340 Pending
NICHD E-058-2021-0-AU-01 La Protein As A Novel Regulator Of Osteoclastogenesis AU National Stage 2022230408 Pending
NIAID E-183-2022-0-PC-01 Multi Protein Nanoparticle Monkeypox Vaccine PCT PCT PCT/US2023/031683 Pending
NCATS E-039-2021-0-CA-01 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION CA National Stage 3212492 Pending
NCI E-169-2022-0-PC-01 Single Domain Antibodies Targeting HPV E6/E7 Oncogenic Peptide/MHC Complexes PCT PCT PCT/US2023/073144 Pending
NICHD E-058-2021-0-US-02 La Protein As A Novel Regulator Of Osteoclastogenesis US National Stage 18/279,476 Pending
NIAID E-007-2015-0-US-02 CD47-targeted Therapies For The Treatment Of Infectious Disease US CON 18/458,903 Pending
NCI E-064-2021-0-EP-01 Adjuvanted Mucosal Subunit Vaccines For Preventing SARS-CoV-2 Transmission And Infection EP National Stage 22705675.1 Pending
NCI E-181-2017-0-NZ-01 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS NZ DIV 803139 Pending
NCI E-175-2016-0-HK-01 ANTI-KRAS-G12D T CELL RECEPTORS HK EP 42023078137.9 Pending
NICHD E-058-2021-0-CA-01 La Protein As A Novel Regulator Of Osteoclastogenesis CA National Stage 3211983 Pending